Page last updated: 2024-08-16

tripelennamine and diclofenac

tripelennamine has been researched along with diclofenac in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (50.00)	29.6817
2010's	1 (50.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Glen, RC; Lowe, R; Mitchell, JB	1
Huang, RC; Kuo, CC; Lou, BS	1

Other Studies

2 other study(ies) available for tripelennamine and diclofenac

Article	Year
Predicting phospholipidosis using machine learning. Molecular pharmaceutics, 2010, Oct-04, Volume: 7, Issue:5 Topics: Animals; Artificial Intelligence; Databases, Factual; Drug Discovery; Humans; Lipidoses; Models, Biological; Phospholipids; Support Vector Machine	2010
Inhibition of Na(+) current by diphenhydramine and other diphenyl compounds: molecular determinants of selective binding to the inactivated channels. Molecular pharmacology, 2000, Volume: 57, Issue:1 Topics: Anesthetics, Local; Animals; Anti-Inflammatory Agents, Non-Steroidal; Binding Sites; Diclofenac; Diphenhydramine; Histamine H1 Antagonists; In Vitro Techniques; Lidocaine; Membrane Potentials; Models, Molecular; Rats; Rats, Long-Evans; Sodium Channel Blockers; Sodium Channels; Structure-Activity Relationship; Tripelennamine	2000

Article

Year

Predicting phospholipidosis using machine learning.

Molecular pharmaceutics, 2010, Oct-04, Volume: 7, Issue:5

Topics: Animals; Artificial Intelligence; Databases, Factual; Drug Discovery; Humans; Lipidoses; Models, Biological; Phospholipids; Support Vector Machine

2010

Inhibition of Na(+) current by diphenhydramine and other diphenyl compounds: molecular determinants of selective binding to the inactivated channels.

Molecular pharmacology, 2000, Volume: 57, Issue:1

Topics: Anesthetics, Local; Animals; Anti-Inflammatory Agents, Non-Steroidal; Binding Sites; Diclofenac; Diphenhydramine; Histamine H1 Antagonists; In Vitro Techniques; Lidocaine; Membrane Potentials; Models, Molecular; Rats; Rats, Long-Evans; Sodium Channel Blockers; Sodium Channels; Structure-Activity Relationship; Tripelennamine

2000